Q2 2018 Holdings
Filed 2018-08-02 | 13 holdings | $135.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Translate Bio | Common Stock | 89374L104 | $30.8K | 2,437,601 | 22.8% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $26.5K | 2,600,410 | 19.6% |
| ObsEva | Common Stock | H5861P103 | $15.1K | 999,664 | 11.2% |
| Kezar Life Sciences | Common Stock | 49372L100 | $12.0K | 693,272 | 8.9% |
| Sienna Biopharmaceuticals(SNNAQ) | Common Stock | 82622H108 | $11.5K | 758,610 | 8.5% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $8.2K | 130,646 | 6.0% |
| Cidara Therapeutics | Common Stock | 171757107 | $7.8K | 1,508,794 | 5.8% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $7.4K | 551,477 | 5.5% |
| Essa Pharma | Common Stock | 29668H104 | $4.1K | 1,084,848 | 3.0% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $4.1K | 529,965 | 3.0% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $3.9K | 778,230 | 2.9% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $2.7K | 223,457 | 2.0% |
| Egalet | Common Stock | 28226B104 | $1.2K | 2,889,926 | 0.9% |